ConductScience.org, home

Paper7249488

Altered plasma protein binding of drugs in thyroid disease.

Feely J and 2 others. Clin Pharmacokinet, 1981. Cited by 26 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Altered plasma protein binding of drugs in thyroid disease. Papers, record 7249488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7249488

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Altered plasma protein binding of drugs in thyroid disease.
PubMed
Journal
Clin Pharmacokinet
PubMed
Year
1981
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
1.67
iCite
Revised in PubMed
2018-11-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Feely JJ
2Stevenson IHI H
3Crooks JJ

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood ProteinsMajor topic
HyperthyroidismMajor topic
HypothyroidismMajor topic
PropranololMajor topic
WarfarinMajor topic
Adolescent
Adult
Aged
Female
Humans
Male
Middle Aged
Protein Binding

Source PubMed

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125,156Diseases and drug protein binding.Clin Pharmacokinet1978https://conductscience.org/library/papers/25156PubMed
24,683,426The effects of dextrothyroxine on the kinetics of prothrombin activity: proposed mechanism of the potentiation of warfarin by D-thyroxine.J Lab Clin Med1973https://conductscience.org/library/papers/4683426PubMed
31,277,545Simple solid-phase radioimmunoassays for total tri-iodothyronine and thyroxine in serum, and their clinical evaluation.Clin Chim Acta1976https://conductscience.org/library/papers/1277545PubMed
41,277,711Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect.Clin Pharmacol Ther1976https://conductscience.org/library/papers/1277711PubMed
5324,687Protein binding of coumarin anticoagulants in disease states.Clin Pharmacokinet1977https://conductscience.org/library/papers/324687PubMed
614,113,369THE BIOLOGICAL DISAPPEARANCE RATE OF PROTHROMBIN, FACTORS VII, IX AND X FROM PLASMA IN HYPOTHYROIDISM, HYPERTHYROIDISM, AND DURING FEVER.Thromb Diath Haemorrh1964https://conductscience.org/library/papers/14113369PubMed
77,212,504Increased clearance of propranolol in thyrotoxicosis.Ann Intern Med1981https://conductscience.org/library/papers/7212504PubMed
8758,239Altered drug binding due to the use of indwelling heparinized cannulas (heparin lock) for sampling.Clin Pharmacol Ther1979https://conductscience.org/library/papers/758239PubMed
963,371Increased plasma binding of quinidine after surgery: a preliminary report.Eur J Clin Pharmacol1976https://conductscience.org/library/papers/63371PubMed
106,053,595The effect of various drugs on the binding of warfarin-14C to human albumin.Biochem Pharmacol1967https://conductscience.org/library/papers/6053595PubMed
115,548,300Radioimmunoassay of human serum thyrotrophin.Br Med J1971https://conductscience.org/library/papers/5548300PubMed
12620,476Biological determinants of propranolol disposition in man.Clin Pharmacol Ther1978https://conductscience.org/library/papers/620476PubMed
134,397,794Drug interactions with coumarin anticoagulants. 2.N Engl J Med1971https://conductscience.org/library/papers/4397794PubMed
141,164,821Commentary: a physiological approach to hepatic drug clearance.Clin Pharmacol Ther1975https://conductscience.org/library/papers/1164821PubMed
154,341,014Plasma triglyceride metabolism in thyroid disease.J Clin Invest1972https://conductscience.org/library/papers/4341014PubMed
164,198,771The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.J Pharmacol Exp Ther1973https://conductscience.org/library/papers/4198771PubMed
17978,453Effects of plasma protein binding of drugs on duration and intensity of pharmacological activity.J Pharm Sci1976https://conductscience.org/library/papers/978453PubMed
181,172,818Warfarin-induced hypoprothrombinemia. Potentiation by hyperthyroidism.JAMA1975https://conductscience.org/library/papers/1172818PubMed
191,234,489Changes in drug metabolism with increasing age: 1. warfarin binding and plasma proteins.Br J Clin Pharmacol1975https://conductscience.org/library/papers/1234489PubMed
2014,482,918Effect of sodium dextrothyroxine in patients receiving anticoagulants.N Engl J Med1962https://conductscience.org/library/papers/14482918PubMed

See all 31 references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
10,749,520Age-related changes in protein binding of drugs: implications for therapy.Clin Pharmacokinet2000https://conductscience.org/library/papers/10749520PubMed
7,104,186Plasma protein binding of phenytoin in 100 epileptic patients.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7104186PubMed
6,639,841Serum protein binding of propylthiouracil.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6639841PubMed
6,419,761Oxazepam pharmacokinetics in thyroid disease.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6419761PubMed
6,166,422Influence of thyroid dysfunction on drug pharmacokinetics.Clin Pharmacokinet1981https://conductscience.org/library/papers/6166422PubMed
6,132,696Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.Clin Pharmacokinet1983https://conductscience.org/library/papers/6132696PubMed
3,606,068Alteration of gentamicin and cefazolin kinetics with control of the hypothyroid state in humans.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3606068PubMed
3,325,214Clinical pharmacokinetics and endocrine disorders. Therapeutic implications.Clin Pharmacokinet1987https://conductscience.org/library/papers/3325214PubMed
2,924,068Pharmacokinetics and dromotropic activity of ajmaline in rats with hyperthyroidism.Br J Pharmacol1989https://conductscience.org/library/papers/2924068PubMed
2,886,244Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update.Clin Pharmacokinet1987https://conductscience.org/library/papers/2886244PubMed
2,338,117Evolution of atenolol kinetics when hypothyroidism is corrected.Eur J Clin Pharmacol1990https://conductscience.org/library/papers/2338117PubMed
2,271,373Pharmacokinetics and pharmacodynamics of oxazepam and metabolism of paracetamol in severe hypothyroidism.Br J Clin Pharmacol1990https://conductscience.org/library/papers/2271373PubMed
2,203,581Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).Clin Pharmacokinet1990https://conductscience.org/library/papers/2203581PubMed
1,458,763Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.Clin Pharmacokinet1992https://conductscience.org/library/papers/1458763PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7249488

GET https://conductscience.org/api/papers/v1/7249488/references?page=2